Microbix Biosystems Inc
TSX:MBX

Watchlist Manager
Microbix Biosystems Inc Logo
Microbix Biosystems Inc
TSX:MBX
Watchlist
Price: 0.3 CAD
Market Cap: 42.3m CAD

Microbix Biosystems Inc
Investor Relations

Microbix Biosystems, Inc. engages in developing and commercializing proprietary biological and technology solutions for human health and wellbeing. The company is headquartered in Mississauga, Ontario. The firm manufactures a range of biological materials for the diagnostics industry, notably antigens (Antigen business) used in immunoassays and its quality assessment and proficiency testing controls (QAPs business). The firm operates in two segments: the development, manufacturing, and sales of antigens as materials for the medical diagnostic industry or as quality assessment products (as finished products) and viral transport medium (VTM) and the development and commercialization of products or technologies such as Kinlytic and . The Kinlyti urokinase, which is a biologic thrombolytic drug used to treat blood clots. The firm's catalogue of catalogue covers a range of pathogens that are implicated in maternal, pediatric, childhood, respiratory, sexually transmitted and insect-borne diseases. Its QAPs are available in over 30 countries.

Show more
Loading
MBX
S&P TSX Composite Index (Canada)
1Y 3Y 5Y 10Y 15Y 20Y

Earnings Calls

Show Transcript
Previous
Next
Loading

Management

Mr. Cameron L. Groome
President, CEO & Director
No Bio Available
Mr. James S. Currie
Chief Financial Officer
No Bio Available
Dr. Kenneth Hughes Ph.D.
Chief Operating Officer
No Bio Available
Dr. Mark Luscher Ph.D.
Senior Vice President of Scientific Affairs
No Bio Available
Mr. Philip Casselli
Senior Vice President of Sales, Business Development & Marketing
No Bio Available
Mr. Christopher B. Lobb
Compliance Officer, General Counsel & Secretary
No Bio Available

Contacts

Address
ONTARIO
Mississauga
265 Watline Avenue
Contacts
+19053618910.0
microbix.com
sparklesyt

See Also

Summary
MBX intrinsic value, competitors valuation, and company profile.
DCF Valuation
MBX stock valuation using Discount Cash Flow valuation method.
Relative Valuation
MBX stock valuation using valuation multiples.
Wall Street Estimates
MBX price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
MBX stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Back to Top
ALPHA SPREAD
Follow us
Join more than 261,100+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.